Atlas Trials

A Transition Study From Flolan® to Remodulin® in Patients With Pulmonary Arterial Hypertension

Clinical trial NCT00058929 · COMPLETED

Trial details

NCT number
NCT00058929
Sponsor
United Therapeutics
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Pulmonary Arterial HypertensionPulmonary Hypertension
Start date
2002-10-01
Primary completion
2005-08-01
Enrollment
39

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.